Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to SHEPP: Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromi.... (0.10 sec) 

Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in …


DH SHEPP, BA NEWTON, PS DANDLIKER, … - Annals of internal …, 1985 - Am Coll Physicians
In a randomized, double-blinded, placebo-controlled trial, we compared the therapeutic effect
of oral acyclovir (400 mg five times daily for 10 days) with that of placebo in patients with marrow
transplants and culture-proven recurrent mucocutaneous herpes simplex. Twelve patients ...
Cited by 82 - Related articles - All 3 versions

Oral acyclovir for prevention of herpes simplex virus reactivation after marrow …


JC WADE, B NEWTON, N FLOURNOY, JD … - Annals of internal …, 1984 - Am Coll Physicians
Oral acyclovir was found to be safe and effective for the prevention of herpes simplex virus reactivation
after marrow transplantation in a double-blind, placebo-controlled trial. Acyclovir or placebo was
administered to 49 patients for 5 weeks beginning 1 week before transplantation: 5 of 24 ...
Cited by 173 - Related articles - All 3 versions

Infections caused by herpes simplex virus in the immunocompromised host: natural …


RJ Whitley, M Levin, N Barton, BJ Hershey, G Davis … - The Journal of infectious …, 1984 - jstor.org
THE JOURNAL OF INFECTIOUS DISEASES . VOL. 150, NO. 3 . SEPTEMBER 1984 (c) 1984
by The University of Chicago. All rights reserved. 0022-1899/84/5003-0002$01.00 ... Infections
Caused by Herpes Simplex Virus in the Immunocompromised Host:
Cited by 71 - Related articles - All 3 versions

Acyclovir prophylaxis against herpes virus infections in severely …


IM Hann, HG Prentice, HA Blacklock, MG Ross, D … - British Medical Journal, 1983 - bmj.com
Twenty patients undergoing allogeneic bone marrow transplantation and 39 patients receiving
remission induction chemotherapy for acute leukaemia were entered into a double blind, placebo
controlled stratified trial of acyclovir prophylaxis against herpes group virus infections. ...
Cited by 82 - Related articles - All 4 versions

Oral acyclovir to suppress recurring herpes simplex virus infections in …


SE STRAUS, M SEIDLIN, H TAKIFF, D … - Annals of internal …, 1984 - Am Coll Physicians
Thirty-two episodes of herpes simplex virus infection in four immunodeficient patients with frequent
recurrences were successfully treated with oral acyclovir, one capsule five times a day for 5
days. In 23 of these episodes, the treatments were extended for 1 to 6 months using two ...
Cited by 80 - Related articles - All 3 versions

Acyclovir prophylaxis against herpes simplex virus infection in patients with …


R SARAL, RF AMBINDER, WH BURNS, CM … - Annals of internal …, 1983 - Am Coll Physicians
Twenty-nine adult patients with acute leukemia receiving timed sequential chemotherapy participated
in a randomized, double-blind, placebo-controlled trial of acyclovir prophylaxis against reactivated
herpes simplex virus infection. Patients with pretreatment antibody titers of 1:16 or greater ...
Cited by 81 - Related articles - All 4 versions

Frequency and significance of acyclovir-resistant herpes simplex virus isolated …


JC Wade, C McLaren, JD Meyers - The Journal of infectious diseases, 1983 - jstor.org
THE JOURNAL OF INFECTIOUS DISEASES - VOL. 148, NO. 6 - DECEMBER 1983 (c) 1983
by The University of Chicago. All rights reserved. 0022-1899/83/4806-0014$00.75 ... Frequency
and Significance of Acyclovir-Resistant Herpes Simplex Virus Isolated
Cited by 111 - Related articles - All 3 versions

Multicenter collaborative trial of intravenous acyclovir for treatment of …


JD Meyers, JC Wade, CD Mitchell, R Saral, … - The American journal of …, 1982 - ncbi.nlm.nih.gov
Intravenous acyclovir was evaluated in the treatment of 97 immunocompromised patients with
mucocutaneous herpes simplex virus infection in a randomized, double-blind, placebo-controlled
trial. Acyclovir recipients had significantly shorter periods of virus shedding (p less than ...
Cited by 166 - Related articles

Vidarabine therapy for mucocutaneous herpes simplex virus infections in the …


RJ Whitley, S Spruance, FG Hayden, J Overall, CA … - The Journal of infectious …, 1984 - jstor.org
THE JOURNAL OF INFECTIOUS DISEASES * VOL. 149, NO. 1 * JANUARY 1984 ... @ 1984
by The University of Chicago. All rights reserved. 0022-1899/84/4901-0001$00.81 ... Vidarabine
Therapy for Mucocutaneous Herpes Simplex Virus Infections ... RJ Whitley, S. Spruance, ...
Cited by 18 - Related articles - All 3 versions

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after …


JC WADE, B NEWTON, C McLAREN, N … - Annals of Internal …, 1982 - Am Coll Physicians
Acyclovir, a new antiviral agent, was compared to a placebo in a randomized double-blind trial
of treatment for culture-proven herpes simplex virus infection after marrow transplantation. Patients
received either intravenous acyclovir at 750 mg/m 2 body surface area per day or a ...
Cited by 198 - Related articles - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 

Go to Google Home - About Google - About Google Scholar

©2009 Google